{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T21:16:29Z","timestamp":1792185389131,"version":"4.4.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T00:00:00Z","timestamp":1717113600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.molmet.2024.101965","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T05:27:24Z","timestamp":1718170044000},"page":"101965","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Lipid-encapsulated mRNA encoding an extended serum half-life interleukin-22 ameliorates metabolic disease in mice"],"prefix":"10.1016","volume":"86","author":[{"given":"Susanna","family":"Canali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander W.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mychael","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorna","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Renee","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiaowen Joyce","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinmayi","family":"Bankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Dussault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Ritchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meagan","family":"Goodridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Sparrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Pannoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sze-Wah","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivienne","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlin","family":"Klovdahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared","family":"Iacovelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmet.2024.101965_bib1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.21037\/atm.2017.03.107","article-title":"Morbidity and mortality associated with obesity","volume":"5","author":"Abdelaal","year":"2017","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.molmet.2024.101965_bib2","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-036663","article-title":"Prevalence trends in non-alcoholic fatty liver disease at the global, regional and national levels, 1990-2017: a population-based observational study","volume":"10","author":"Ge","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.molmet.2024.101965_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.838027","article-title":"Prevalence, deaths and disability-adjusted-life-years (DALYs) due to type 2 diabetes and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019","volume":"13","author":"Safiri","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.molmet.2024.101965_bib4","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/gutjnl-2020-322786","article-title":"Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort","volume":"70","author":"Simon","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.molmet.2024.101965_bib6","year":"2022","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2024.101965_bib7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.7861\/clinmedicine.19-3-205","article-title":"Current treatments for obesity","volume":"19","author":"Ruban","year":"2019","journal-title":"Clin Med"},{"key":"10.1016\/j.molmet.2024.101965_bib8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2147\/HMER.S188991","article-title":"A\u00a0review of current and upcoming treatment modalities in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis","volume":"11","author":"Ganguli","year":"2019","journal-title":"Hepatic Med"},{"key":"10.1016\/j.molmet.2024.101965_bib9","doi-asserted-by":"crossref","first-page":"354","DOI":"10.4239\/wjd.v7.i17.354","article-title":"Update on the treatment of type 2 diabetes mellitus","volume":"7","author":"Marin-Penalver","year":"2016","journal-title":"World J Diabetes"},{"key":"10.1016\/j.molmet.2024.101965_bib10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41423-020-00580-w","article-title":"Immunopathobiology and therapeutic targets related to cytokines in liver diseases","volume":"18","author":"He","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.molmet.2024.101965_bib11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature13564","article-title":"Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes","volume":"514","author":"Wang","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.molmet.2024.101965_bib12","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1016\/j.febslet.2008.07.046","article-title":"Crystal structure of the IL-22\/IL-22R1 complex and its implications for the IL-22 signaling mechanism","volume":"582","author":"Bleicher","year":"2008","journal-title":"FEBS Lett"},{"key":"10.1016\/j.molmet.2024.101965_bib13","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41423-018-0055-6","article-title":"Interleukin-22 from bench to bedside: a promising drug for epithelial repair","volume":"16","author":"Gao","year":"2019","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.molmet.2024.101965_bib14","doi-asserted-by":"crossref","first-page":"33676","DOI":"10.1074\/jbc.M204204200","article-title":"Interleukin-22 (IL-22) activates the JAK\/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10","volume":"277","author":"Lejeune","year":"2002","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molmet.2024.101965_bib15","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.3390\/biomedicines9121912","article-title":"Therapeutic opportunities of IL-22 in non-alcoholic fatty liver disease: from molecular mechanisms to clinical applications","volume":"9","author":"Zai","year":"2021","journal-title":"Biomedicines"},{"issue":"168","key":"10.1016\/j.molmet.2024.101965_bib16","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.4049\/jimmunol.168.11.5397","article-title":"Cutting edge: immune cells as sources and targets of the IL-10 family members?","author":"Wolk","year":"2002","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.molmet.2024.101965_bib17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.immuni.2004.07.007","article-title":"IL-22 increases the innate immunity of tissues","volume":"21","author":"Wolk","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.molmet.2024.101965_bib18","doi-asserted-by":"crossref","first-page":"10144","DOI":"10.1073\/pnas.170291697","article-title":"Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor","volume":"97","author":"Dumoutier","year":"2000","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.molmet.2024.101965_bib19","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1089\/107999001317205178","article-title":"Acinar cells of the pancreas are a target of interleukin-22","volume":"21","author":"Aggarwal","year":"2001","journal-title":"J\u00a0Interf Cytok Res"},{"key":"10.1016\/j.molmet.2024.101965_bib20","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/hep.24339","article-title":"In\u00a0vivo consequences of liver-specific interleukin-22 expression in mice: implications for human liver disease progression","volume":"54","author":"Park","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.molmet.2024.101965_bib21","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.immuni.2007.07.023","article-title":"Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation","volume":"27","author":"Zenewicz","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.molmet.2024.101965_bib22","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/hep.31031","article-title":"Interleukin-22 ameliorates neutrophil-driven nonalcoholic steatohepatitis through multiple targets","volume":"72","author":"Hwang","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.molmet.2024.101965_bib23","doi-asserted-by":"crossref","first-page":"G74","DOI":"10.1152\/ajpgi.00075.2009","article-title":"IL-22 is involved in liver regeneration after hepatectomy","volume":"298","author":"Ren","year":"2010","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.molmet.2024.101965_bib24","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/hep.23837","article-title":"Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3","volume":"52","author":"Ki","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.molmet.2024.101965_bib25","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/nm.3705","article-title":"Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stress","volume":"20","author":"Hasnain","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.molmet.2024.101965_bib26","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41423-018-0029-8","article-title":"Safety, pharmacokinetics, and biomarkers of F-652, a recombinant human interleukin-22 dimer, in healthy subjects","volume":"16","author":"Tang","year":"2019","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.molmet.2024.101965_bib27","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s13318-020-00664-y","article-title":"Prediction of half-life extension of peptides via serum albumin binding: current challenges","volume":"46","author":"Hijazi","year":"2021","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.molmet.2024.101965_bib28","article-title":"Albumin fusion of interleukin-28B: production and characterization of its biological activities and protein stability","volume":"8","author":"Zhao","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.molmet.2024.101965_bib29","article-title":"Enhancing a half-life and biological activity of IL-15 using a serum albumin-specific protein binder","author":"Kim","year":"2022","journal-title":"SSRN Preprint"},{"key":"10.1016\/j.molmet.2024.101965_bib30","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/hep.31046","article-title":"An open-label, dose-escalation study to assess the safety and efficacy of IL-22 agonist F-652 in patients with alcohol-associated hepatitis","volume":"72","author":"Arab","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.molmet.2024.101965_bib32","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1248\/bpb.b19-00743","article-title":"Lipid nanoparticles for cell-specific in\u00a0vivo targeted delivery of nucleic acids","volume":"43","author":"Khalil","year":"2020","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.molmet.2024.101965_bib33","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.3390\/pharmaceutics13091472","article-title":"mRNA-based nanomedicinal products to address corneal inflammation by interleukin-10 supplementation","volume":"13","author":"Gomez-Aguado","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.molmet.2024.101965_bib34","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s40425-018-0431-x","article-title":"Lipid nanoparticles that deliver IL-12 messenger RNA suppress tumorigenesis in MYC oncogene-driven hepatocellular carcinoma","volume":"6","author":"Lai","year":"2018","journal-title":"J\u00a0Immunother Cancer"},{"key":"10.1016\/j.molmet.2024.101965_bib35","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1038\/s41467-022-31130-9","article-title":"Selective activation and expansion of regulatory T cells using lipid encapsulated mRNA encoding a long-acting IL-2 mutein","volume":"13","author":"de Picciotto","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.molmet.2024.101965_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120786","article-title":"Granulocyte-macrophage colony-stimulating factor mRNA and neuroprotective immunity in Parkinson's disease","volume":"272","author":"Olson","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.molmet.2024.101965_bib37","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat Rev Mater"},{"key":"10.1016\/j.molmet.2024.101965_bib38","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41586-020-2622-0","article-title":"SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness","volume":"586","author":"Corbett","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.molmet.2024.101965_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtn.2019.01.013","article-title":"Optimization of lipid nanoparticles for intramuscular administration of mRNA vaccines","volume":"15","author":"Hassett","year":"2019","journal-title":"Mol Therapy Nucleic Acids"},{"key":"10.1016\/j.molmet.2024.101965_bib41","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.3748\/wjg.v25.i33.4904","article-title":"Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: impact of dietary fat source","volume":"25","author":"Boland","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.molmet.2024.101965_bib42","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.metabol.2014.04.003","article-title":"De novo lipogenesis in health and disease","volume":"63","author":"Ameer","year":"2014","journal-title":"Metabolism"},{"key":"10.1016\/j.molmet.2024.101965_bib43","doi-asserted-by":"crossref","first-page":"673","DOI":"10.4254\/wjh.v8.i16.673","article-title":"Obese diet-induced mouse models of nonalcoholic steatohepatitis-tracking disease by liver biopsy","volume":"8","author":"Kristiansen","year":"2016","journal-title":"World J Hepatol"},{"key":"10.1016\/j.molmet.2024.101965_bib44","doi-asserted-by":"crossref","first-page":"E487","DOI":"10.1152\/ajpendo.00443.2018","article-title":"Intact innervation is essential for diet-induced recruitment of brown adipose tissue","volume":"316","author":"Fischer","year":"2019","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.molmet.2024.101965_bib45","doi-asserted-by":"crossref","first-page":"7433","DOI":"10.1038\/ncomms8433","article-title":"Cidea improves the metabolic profile through expansion of adipose tissue","volume":"6","author":"Abreu-Vieira","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.molmet.2024.101965_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101173","article-title":"TFEB deficiency attenuates mitochondrial degradation upon brown adipose tissue whitening at thermoneutrality","volume":"47","author":"Sass","year":"2021","journal-title":"Mol Metabol"},{"key":"10.1016\/j.molmet.2024.101965_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115922","article-title":"Establishment of a general NAFLD scoring system for rodent models and comparison to human liver pathology","volume":"9","author":"Liang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.molmet.2024.101965_bib48","first-page":"1","article-title":"Fitting linear mixed-effects models using lme4","volume":"67","author":"Bates","year":"2015","journal-title":"J\u00a0Stat Softw"},{"key":"10.1016\/j.molmet.2024.101965_bib49","series-title":"Mixed-effects models in S and S-PLUS","author":"Pinheiro","year":"2000"},{"key":"10.1016\/j.molmet.2024.101965_bib50","first-page":"1","article-title":"Bayesian item response modeling in R with brms and Stan","volume":"100","author":"B\u00fcrkner","year":"2021","journal-title":"J\u00a0Stat Softw"},{"key":"10.1016\/j.molmet.2024.101965_bib51","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.2517-6161.1964.tb00553.x","article-title":"An analysis of transformations","volume":"26","author":"Box","year":"1964","journal-title":"J\u00a0Roy Stat Soc B Stat Methodol"},{"key":"10.1016\/j.molmet.2024.101965_bib52","series-title":"Emmeans: estimated marginal means, aka least-squares means, 1.8.2 ed","author":"Lenth","year":"2022"},{"key":"10.1016\/j.molmet.2024.101965_bib53","series-title":"A\u00a0language and environment for statistical computing, 4.1.0 ed","year":"2021"},{"key":"10.1016\/j.molmet.2024.101965_bib54","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/HEP.0000000000000239","article-title":"Environmental eustress promotes liver regeneration through the sympathetic regulation of type 1 innate lymphoid cells to increase IL-22 in mice","volume":"78","author":"Liu","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.molmet.2024.101965_bib55","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/S0022-2275(20)39866-7","article-title":"Transgenic mice expressing both human apolipoprotein B and human CETP have a lipoprotein cholesterol distribution similar to that of normolipidemic humans","volume":"36","author":"Grass","year":"1995","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.molmet.2024.101965_bib56","series-title":"Medication routes of administration","author":"Kim","year":"2023"},{"key":"10.1016\/j.molmet.2024.101965_bib81","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.immuni.2004.07.007","article-title":"IL-22 increases the innate immunity of tissues","volume":"21","author":"Wolk","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.molmet.2024.101965_bib83","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nm1720","article-title":"Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens","volume":"14","author":"Zheng","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.molmet.2024.101965_bib84","doi-asserted-by":"crossref","first-page":"766586","DOI":"10.3389\/fimmu.2021.766586","article-title":"IL-22 binding protein (IL-22BP) in the regulation of IL-22 biology","volume":"12","author":"Zenewicz","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.molmet.2024.101965_bib57","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1210\/en.2011-2170","article-title":"Overlap of endocrine hormone expression in the mouse intestine revealed by transcriptional profiling and flow cytometry","volume":"153","author":"Habib","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2024.101965_bib58","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nature00887","article-title":"Gut hormone PYY(3-36) physiologically inhibits food intake","volume":"418","author":"Batterham","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.molmet.2024.101965_bib59","doi-asserted-by":"crossref","first-page":"77","DOI":"10.18869\/acadpub.ibj.21.2.77","article-title":"Evaluation of an albumin-binding domain protein fused to recombinant human IL-2 and its effects on the bioactivity and serum half-life of the cytokine","volume":"21","author":"Adabi","year":"2017","journal-title":"Iran Biomed J"},{"key":"10.1016\/j.molmet.2024.101965_bib60","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/s41467-023-37142-3","article-title":"Deficiency of gluconeogenic enzyme PCK1 promotes metabolic-associated fatty liver disease through PI3K\/AKT\/PDGF axis activation in male mice","volume":"14","author":"Ye","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.molmet.2024.101965_bib61","doi-asserted-by":"crossref","DOI":"10.1038\/srep16920","article-title":"Beneficial impact of Gpnmb and its significance as a biomarker in nonalcoholic steatohepatitis","volume":"5","author":"Katayama","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.molmet.2024.101965_bib62","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.molcel.2019.07.028","article-title":"Landscape of intercellular crosstalk in healthy and NASH liver revealed by single-cell secretome gene analysis","volume":"75","author":"Xiong","year":"2019","journal-title":"Mol Cell"},{"key":"10.1016\/j.molmet.2024.101965_bib63","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1194\/jlr.R800018-JLR200","article-title":"Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis","volume":"49","author":"Yen","year":"2008","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.molmet.2024.101965_bib64","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.3390\/polym13162642","article-title":"Current insights into collagen type I","volume":"13","author":"Naomi","year":"2021","journal-title":"Polymers"},{"key":"10.1016\/j.molmet.2024.101965_bib65","doi-asserted-by":"crossref","first-page":"E713","DOI":"10.1152\/ajpendo.00194.2007","article-title":"Macrophage TNF-\u03b1 contributes to insulin resistance and hepatic steatosis in diet-induced obesity","volume":"293","author":"De Taeye","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.molmet.2024.101965_bib66","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/cac2.12084","article-title":"A\u00a0newly discovered role of metabolic enzyme PCK1 as a protein kinase to promote cancer lipogenesis","volume":"40","author":"Jiang","year":"2020","journal-title":"Cancer Commun"},{"key":"10.1016\/j.molmet.2024.101965_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.mgene.2020.100798","article-title":"Fatty acid synthesis and cancer: aberrant expression of the ACACA and ACACB genes increases the risk for cancer","volume":"26","author":"Bhattacharjee","year":"2020","journal-title":"Meta Gene"},{"key":"10.1016\/j.molmet.2024.101965_bib68","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.tem.2017.10.003","article-title":"Insights into stearoyl-CoA desaturase-1 regulation of systemic metabolism","volume":"28","author":"Aljohani","year":"2017","journal-title":"Trends Endocrinol Metabol"},{"key":"10.1016\/j.molmet.2024.101965_bib69","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41573-021-00367-2","article-title":"Lipogenesis inhibitors: therapeutic opportunities and challenges","volume":"21","author":"Batchuluun","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.molmet.2024.101965_bib70","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jhep.2010.03.004","article-title":"Amelioration of high fat diet induced liver lipogenesis and hepatic steatosis by interleukin-22","volume":"53","author":"Yang","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.molmet.2024.101965_bib71","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/hep.25744","article-title":"Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice","volume":"56","author":"Kong","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.molmet.2024.101965_bib72","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1002\/oby.23773","article-title":"The effect of weight loss on whole-body and tissue-specific insulin sensitivity and hepatic lipid content and composition: SWEET substudy","volume":"31","author":"Pang","year":"2023","journal-title":"Obesity"},{"key":"10.1016\/j.molmet.2024.101965_bib73","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1055\/s-0028-1091979","article-title":"Abnormalities of lipid metabolism in nonalcoholic fatty liver disease","volume":"28","author":"Cheung","year":"2008","journal-title":"Semin Liver Disease"},{"key":"10.1016\/j.molmet.2024.101965_bib74","doi-asserted-by":"crossref","first-page":"22Q","DOI":"10.1016\/S0002-9149(98)00770-X","article-title":"Triglyceride as a risk factor for coronary artery disease","volume":"82","author":"Gotto","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.molmet.2024.101965_bib75","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.bbalip.2016.03.004","article-title":"HDL functionality in reverse cholesterol transport-challenges in translating data emerging from mouse models to human disease","volume":"1861","author":"Lee-Rueckert","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.molmet.2024.101965_bib76","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11906-018-0812-z","article-title":"The global epidemic of the metabolic syndrome","volume":"20","author":"Saklayen","year":"2018","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.molmet.2024.101965_bib77","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.2337\/dc19-0707","article-title":"The cardiometabolic risk profile of young adults with diabetes in the U.S","volume":"42","author":"Saydah","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.molmet.2024.101965_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2022.111776","article-title":"Down-regulating Interleukin-22\/Interleukin-22 binding protein axis promotes inflammation and aggravates diet-induced metabolic disorders","volume":"557","author":"Gu","year":"2022","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.molmet.2024.101965_bib79","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1056\/NEJMoa030204","article-title":"Inhibition of food intake in obese subjects by peptide YY3-36","volume":"349","author":"Batterham","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.molmet.2024.101965_bib80","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1053\/j.gastro.2005.09.001","article-title":"Effect of peptide YY3-36 on food intake in humans","volume":"129","author":"Degen","year":"2005","journal-title":"Gastroenterology"}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877824000966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877824000966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T11:53:10Z","timestamp":1721303590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212877824000966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":80,"alternative-id":["S2212877824000966"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2024.101965","relation":{},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid-encapsulated mRNA encoding an extended serum half-life interleukin-22 ameliorates metabolic disease in mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2024.101965","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"101965"}}